Insulin deficiency induces rat renal mesangial cell dysfunction via activation of IGF-1/IGF-1R pathway

• Published in: Acta pharmacologica Sinica 2016-02, Vol.37 (2), p.217-227
• Main Authors: Kong, Ya-li, Shen, Yang, Ni, Jun, Shao, De-cui, Miao, Nai-jun, Xu, Jin-lan, Zhou, Li, Xue, Hong, Zhang, Wei, Wang, Xiao-xia, Lu, Li-min
• Format: Article
• Language: English
• Subjects: Animals; Biomedical and Life Sciences; Biomedicine; Cell Line; Cell Proliferation; Diabetes Mellitus, Experimental - complications; Diabetes Mellitus, Experimental - metabolism; Diabetes Mellitus, Experimental - pathology; Diabetic Nephropathies - metabolism; Diabetic Nephropathies - pathology; Immunology; Insulin - metabolism; Insulin-Like Growth Factor I - metabolism; Internal Medicine; Kidney - metabolism; Kidney - pathology; Male; Medical Microbiology; Mesangial Cells - metabolism; Mesangial Cells - pathology; Original; original-article; Pharmacology/Toxicology; Rats; Rats, Sprague-Dawley; Receptor, IGF Type 1 - metabolism; Signal Transduction; Vaccine; 制剂; 处方; 药学; 药理
• ISSN: 1671-4083; 1745-7254
• DOI: 10.1038/aps.2015.128

Aim： Diabetic nephropathy is one of the major complications of diabetes and the major cause of end-stage renal disease. In this study we investigated the insulin deficiency （ID） induced changes in renal mesangial cells （MCs） and in the kidney of STZ-induced diabetic rats. Methods： Cultured rat renal MCs were incubated in ID media. Cell proliferation was analyzed using BrdU incorporation assay. The expression of insulin receptor （IR）, insulin-like growth factor-1 receptor （IGF-1R）, phosphorylated IGF-1R, fibronectin, and collagen IV was determined with Western blot analysis. STZ-induced diabetic rats were treated with an IGF-1R antagonist picropodophyllin （PPP, 20 mg.k-1.d-1, pc） for 8 weeks. After the rats were euthanized, plasma and kidneys were collected. IGF-1 levels in renal cortex were measured with RT-PCR or ELISA. The morphological changes in the kidneys were also examined. Results： Incubation in ID media significantly increased cell proliferation, the synthesis of fibronectin and collagen IV, and the expression of IGF-1 and IGF-1R and phosphorylated IGF-1R in renal MCs. Pretreatment of the cells with PPP （50 nmol/L） blocked ID-induced increases in cell proliferation and the synthesis of fibronectin and collagen IV; knockdown of IGF-1R showed a similar effect as PPP did. In contrast, treatment of the cells with IGF-1 （50 ng/mL） exacerbated ID-induced increases in cell proliferation. In the kidneys of diabetic rats, the expression of IGF-1, IGF-1R and phosphorylated IGF-1R were significantly elevated. Treatment of diabetic rats with PPP did not lower the blood glucose levels, but significantly suppressed the expression of TGF-β, fibronectin and collagen IV in the kidneys, the plasma levels of urinary nitrogen and creatinine, and the urinary protein excretion. Conclusion： Insulin deficiency increases the expression of IGF-1 and IGF-1R in renal MCs and the kidney of diabetic rats, which contributes to the development of diabetic nephropathy.